» Articles » PMID: 20563532

The Role and Therapeutic Potential of Endothelial Progenitor Cells in Tumor Neovascularization

Overview
Publisher Wiley
Specialty Biology
Date 2010 Jun 22
PMID 20563532
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Although the cellular and molecular mechanisms of tumor growth and metastasis are not completely understood, it is established that formation and growth of new blood vessels is a conditio sine qua non for tumor survival, growth, and expansion. Numerous studies over the past decades demonstrated that neovascularization associated with tumor growth occurs via angiogenic and vasculogenic mechanisms that involve sprouting angiogenesis, intussusceptive angiogenesis, vessel co-option, vasculogenic mimicry, lymphangiogenesis, and the recruitment of endothelial progenitor cells (EPCs). Due to their ability to self-renew, circulate, home to the ischemic sites, and differentiate into mature endothelial cells, EPCs hold enormous potential to be used as a diagnostic and/or therapeutic agent in antitumor therapies. Hence, this review focuses on EPCs and their role in tumor angiogenesis with the emphasis on EPC recruitment/migration, and the potential use of EPCs as a therapeutic tool and imaging probe.

Citing Articles

Therapeutic potential of vasculogenic mimicry in urological tumors.

Lin X, Long S, Yan C, Zou X, Zhang G, Zou J Front Oncol. 2023; 13:1202656.

PMID: 37810976 PMC: 10551447. DOI: 10.3389/fonc.2023.1202656.


MMP-sensitive PEG hydrogel modified with RGD promotes bFGF, VEGF and EPC-mediated angiogenesis.

Ouyang L, Dan Y, Shao Z, Yang S, Yang C, Liu G Exp Ther Med. 2019; 18(4):2933-2941.

PMID: 31572536 PMC: 6755480. DOI: 10.3892/etm.2019.7885.


Influence of buffy coat-derived putative endothelial progenitor cells on tumor growth and neovascularization in oral squamous cell carcinoma xenografts.

Otto M, Blatt S, Pabst A, Mandic R, Schwarz J, Neff A Clin Oral Investig. 2019; 23(10):3767-3775.

PMID: 30693401 DOI: 10.1007/s00784-019-02806-2.


Glucocorticoid Impaired the Wound Healing Ability of Endothelial Progenitor Cells by Reducing the Expression of CXCR4 in the PGE2 Pathway.

Carolina E, Kato T, Khanh V, Moriguchi K, Yamashita T, Takeuchi K Front Med (Lausanne). 2018; 5:276.

PMID: 30324106 PMC: 6173212. DOI: 10.3389/fmed.2018.00276.


MicroRNA-210 Promotes Accumulation of Neural Precursor Cells Around Ischemic Foci After Cerebral Ischemia by Regulating the SOCS1-STAT3-VEGF-C Pathway.

Meng Z, Kang H, Duan W, Zheng J, Li Q, Zhou Z J Am Heart Assoc. 2018; 7(5).

PMID: 29478968 PMC: 5866312. DOI: 10.1161/JAHA.116.005052.


References
1.
Peters B, Diaz L, Polyak K, Meszler L, Romans K, Guinan E . Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med. 2005; 11(3):261-2. DOI: 10.1038/nm1200. View

2.
Kermani P, Rafii D, Jin D, Whitlock P, Schaffer W, Chiang A . Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest. 2005; 115(3):653-63. PMC: 1051987. DOI: 10.1172/JCI22655. View

3.
Zhang H, Vakil V, Braunstein M, Smith E, Maroney J, Chen L . Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood. 2004; 105(8):3286-94. DOI: 10.1182/blood-2004-06-2101. View

4.
Massa M, Rosti V, Ramajoli I, Campanelli R, Pecci A, Viarengo G . Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. J Clin Oncol. 2005; 23(24):5688-95. DOI: 10.1200/JCO.2005.09.021. View

5.
Wierzbowska A, Robak T, Krawczynska A, Wrzesien-Kus A, Pluta A, Cebula B . Circulating endothelial cells in patients with acute myeloid leukemia. Eur J Haematol. 2005; 75(6):492-7. DOI: 10.1111/j.1600-0609.2005.00549.x. View